Yuhan Corp (000100):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Yuhan Corp (000100) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10107
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Yuhan Corp (Yuhan) researches, develops, manufactures and markets pharmaceutical products. The company offers API’s and intermediates for antibiotic, antiviral, antifungal, anti-inflammatory, anti-diabetic, anti-HIV, anti-HCV, beta-lactase inhibitors, PEGlyated compounds and anti-histamines. It offers finished goods for the treatment of coronary artery disease, hypertension, hyperlipidemia, cerebral thrombosis and other diseases. The company provides custom synthesis services for other pharmaceutical and biopharmaceutical companies. It offers active pharmaceutical ingredients (API) and finished products in domestic and also international market. Yuhan operates R&D and manufacturing facilities in Seoul. It offers its products and services through its sales and distribution branches. Yuhan is headquartered in Seoul, South Korea.

Yuhan Corp (000100) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Yuhan Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Yuhan Corp, Medical Devices Deals, 2012 to YTD 2018 9
Yuhan Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Yuhan Corp, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Yuhan to Enter into Agreement with GC Pharma 11
Yuhan Enters into Agreement with Syntekabio 12
Sorrento Therapeutics Forms Joint Venture with Yuhan 13
Licensing Agreements 14
Janssen Biotech Enters into Licensing Agreement with Yuhan 14
Yuhan Enters into Licensing Agreement with Samsung Bioepis 15
Yuhan Enters into Licensing Agreement with Bioneer 16
Cevec Pharma Enters Into Licensing Agreement With Yuhan To Develop Therapeutic Proteins 17
Equity Offering 18
Sorrento Therapeutics Raises USD10 Million in Private Placement of Shares and Warrants 18
Acquisition 20
Yuhan Completes Acquisition Of 9.1% Stake In Hanall For US$27 Million 20
Yuhan Corp – Key Competitors 21
Yuhan Corp – Key Employees 22
Yuhan Corp – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Affiliate 24
Joint Venture 24
Recent Developments 25
Strategy And Business Planning 25
Nov 05, 2018: Yuhan licences lung cancer asset to Janssen in $1.25bn deal 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Yuhan Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Yuhan Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Yuhan Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Yuhan Corp, Medical Devices Deals, 2012 to YTD 2018 9
Yuhan Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Yuhan to Enter into Agreement with GC Pharma 11
Yuhan Enters into Agreement with Syntekabio 12
Sorrento Therapeutics Forms Joint Venture with Yuhan 13
Janssen Biotech Enters into Licensing Agreement with Yuhan 14
Yuhan Enters into Licensing Agreement with Samsung Bioepis 15
Yuhan Enters into Licensing Agreement with Bioneer 16
Cevec Pharma Enters Into Licensing Agreement With Yuhan To Develop Therapeutic Proteins 17
Sorrento Therapeutics Raises USD10 Million in Private Placement of Shares and Warrants 18
Yuhan Completes Acquisition Of 9.1% Stake In Hanall For US$27 Million 20
Yuhan Corp, Key Competitors 21
Yuhan Corp, Key Employees 22
Yuhan Corp, Other Locations 23
Yuhan Corp, Subsidiaries 23
Yuhan Corp, Affiliate 24
Yuhan Corp, Joint Venture 24

List of Figures
Yuhan Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Yuhan Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Yuhan Corp, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Yuhan Corp (000100):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mitsubishi Corporation:企業の戦略・SWOT・財務分析
    Mitsubishi Corporation - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Investitionsbank Berlin:企業の戦略・SWOT・財務分析
    Investitionsbank Berlin - Strategy, SWOT and Corporate Finance Report Summary Investitionsbank Berlin - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Logitech International S.A.:企業の戦略・SWOT・財務分析
    Logitech International S.A. - Strategy, SWOT and Corporate Finance Report Summary Logitech International S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Ardelyx Inc (ARDX):製薬・医療:M&Aディール及び事業提携情報
    Summary Ardelyx Inc (Ardelyx) is a developer of small molecule therapeutics for treatment of cardio-renal, gastrointestinal and metabolic disorders. The company provides product portfolio such as tenapanor, RDX227675, RDX98940 and RDX013, among others. Its products are used for hyperphosphatemia in …
  • Intercept Pharmaceuticals Inc (ICPT):企業の財務・戦略的SWOT分析
    Intercept Pharmaceuticals Inc (ICPT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Mallinckrodt, LLC-製薬・医療分野:企業M&A・提携分析
    Summary Mallinckrodt LLC (Mallinckrodt), a subsidiary of Mallinckrodt Plc is a biophramaceutical company that develops medicines. The company manufactures, markets and distributes generic and specialty pharmaceuticals, active pharmaceutical ingredients, diagnostic imaging agents, global medical imag …
  • PaxVax Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary PaxVax Inc (PaxVax) is a vaccine company that develops and commercializes specialty vaccines against infectious diseases. The company develops scalable, and oral vaccines. Its activities include early-stage preclinical research and development, clinical study support, drug product manufactur …
  • Guy’s and St Thomas’ NHS Foundation Trust:企業の戦略的SWOT分析
    Guy's and St Thomas' NHS Foundation Trust - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Recruit Holdings Co., Ltd.:企業の戦略・SWOT・財務情報
    Recruit Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Recruit Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • CIMIC Group Limited:企業の戦略・SWOT・財務情報
    CIMIC Group Limited - Strategy, SWOT and Corporate Finance Report Summary CIMIC Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Ctrip.Com International Ltd:企業の戦略・SWOT・財務分析
    Ctrip.Com International Ltd - Strategy, SWOT and Corporate Finance Report Summary Ctrip.Com International Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Bunzl plc (BNZL):企業の財務・戦略的SWOT分析
    Bunzl plc (BNZL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Ansaldo Energia SpA:企業の戦略的SWOT分析
    Ansaldo Energia SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Evergreen Packaging Llc:企業の戦略・SWOT・財務分析
    Evergreen Packaging Llc - Strategy, SWOT and Corporate Finance Report Summary Evergreen Packaging Llc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Bio-Rad Laboratories Inc (BIO):医療機器:M&Aディール及び事業提携情報
    Summary Bio-Rad Laboratories Inc (Bio-Rad) develops, manufactures and markets a range of products and systems for the life science research, healthcare, analytical chemistry and other markets. The company’s major products include reagents, apparatus, laboratory instruments, test systems, informatics …
  • ING Life Insurance Company Korea, Ltd.:企業の戦略・SWOT・財務情報
    ING Life Insurance Company Korea, Ltd. - Strategy, SWOT and Corporate Finance Report Summary ING Life Insurance Company Korea, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • At Home Group Inc. (HOME):企業の財務・戦略的SWOT分析
    At Home Group Inc. (HOME) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Rohto Pharmaceutical Co Ltd (4527):製薬・医療:M&Aディール及び事業提携情報
    Summary Rohto Pharmaceutical Co Ltd (Rohto Pharmaceutical) is a pharmaceutical company that manufactures and markets cosmetics and functional foods. The company offers products such as eye care products, skin care products, oral medicine product, cosmetics, eye drops, gastrointestinal medicines, der …
  • Jo-Ann Stores, Inc.:企業の戦略・SWOT・財務情報
    Jo-Ann Stores, Inc. - Strategy, SWOT and Corporate Finance Report Summary Jo-Ann Stores, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Cairn Energy Plc (CNE):企業の財務・戦略的SWOT分析
    Cairn Energy Plc (CNE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆